Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy of Influenza Vaccine in HIV Infected Adults.

Next Previous
Trial Profile

Efficacy of Influenza Vaccine in HIV Infected Adults.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Sep 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Therapeutic Use

Most Recent Events

  • 01 Jan 2011 Results from the immunogenicity sub-study were published in Clinical infectious diseases: an official publication of the Infectious Diseases Society of America.
  • 01 Jan 2011 Results published in Clinical infectious diseases: an official publication of the Infectious Diseases Society of America.
  • 22 Jul 2009 Interim results reported at 5th IAS conference on HIV pathogenesis, treatment and prevevntion, 2009, South Africa.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top